2018 ESC/ESH Guidelines for the management of arterial hypertension

Cited by (1,025)

Items 301–400 of 1,025

1. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
   B. Godman, H. McCabe, T. Leong, D. Mueller, A. Martin, Iris Hoxha, J. Mwita, G. Rwegerera, A. Massele, Juliana de Oliveira Costa et al. · 2020 · Expert review of pharmacoeconomics & outcomes research
2. Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19
   Enrique Rodilla, Alberto Saura, Iratxe Jiménez, Andrea Mendizábal, Araceli Pineda Cantero, Elizabeth Lorenzo-Hernández, Maria Del Pilar Fidalgo-Montero, Joaquín Fernández López-Cuervo, Ricardo Gil Sánchez, Elisa Rabadán Pejenaute et al. · 2020 · Journal of Clinical Medicine
3. Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
   Giuseppe Boriani, Marco Vitolo, Igor Diemberger, Marco Proietti, Anna Chiara Valenti, Vincenzo Livio Malavasi, Gregory Y.H. Lip · 2021 · Cardiovascular Research
4. Digital Therapeutics in Hypertension: Evidence and Perspectives
   Kazuomi Kario, Noriko Harada, Ayako Okura · 2022 · Hypertension
5. Effectiveness of nurse-led interventions versus usual care to manage hypertension and lifestyle behaviour: a systematic review and meta-analysis
   Lemma N Bulto, Jacqueline Roseleur, Sara Noonan, Maria Alejandra Pinero de Plaza, Stephanie Champion, Hila Ariela Dafny, Vincent Pearson, Katie Nesbitt, Lemlem Gebremedhin Gebremichael, Alline Maria R. Beleigoli et al. · 2023 · European Journal of Cardiovascular Nursing
6. Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
   Irene V. Lambrinoudaki, Eleni Armeni, Dimitrios G. Goulis, Silvia Bretz, Iuliana Ceauşu, Fatih Durmuşoğlu, Risto Erkkola, Ivan Fistonić, Marco Gambacciani, Marije Geukes et al. · 2022 · Maturitas
7. Fixed‐dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications
   Donald J. DiPette, Jamario Skeete, Emily Ridley, Norm R.C. Campbell, Patricio A López-Jaramillo, Sandeep P. Kishore, Marc G. Jaffe, António Coca, Raymond R. Townsend, Pedro Ordúñez · 2018 · Journal of Clinical Hypertension
8. Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
   Felix Mahfoud, Michel Azizi, Sebastian Ewen, Atul Pathak, Christian Ukena, Peter J. Blankestijn, Michael Böhm, Michel Burnier, Gilles Châtellier, Isabelle Durand‐Zaleski et al. · 2020 · European Heart Journal
9. Nomenclature for kidney function and disease—executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
   Andrew S. Levey, Kai‐Uwe Eckardt, Nijsje M. Dorman, Stacy L. Christiansen, Michael Cheung, Michel Y. Jadoul, Wolfgang C. Winkelmayer­ · 2020 · European Heart Journal
10. Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review
    Emmanuel Messas, Guillaume Goudot, Alison W Halliday, Jonas Sitruk, Tristan Mirault, Lina Khider, Frédéric Saldmann, Lucia Mazzolai, Victor Aboyans · 2020 · European Heart Journal Supplements
11. Sodium intake, life expectancy, and all-cause mortality
    Franz H. Messerli, Louis Hofstetter, Lamprini Syrogiannouli, Emrush Rexhaj, George C.M. Siontis, Christian A. Seiler, Sripal Bangalore · 2020 · European Heart Journal
12. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic
    Reinhold Hugo Kreutz, Piotr Dobrowolski, Aleksander Prejbisz, Engi Abd Elhady Algharably, Grzegorz Bilo, Felix Creutzig, Guido M. Grassi, Vasilios Kotsis, Dragan B. Lović, Empar Lurbe et al. · 2020 · Journal of Hypertension
13. Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management
    Jakub Janusz Gumprecht, Magdalena Domek, Gregory Y.H. Lip, Alena Shantsila · 2019 · Journal of Human Hypertension
14. Inherited Thoracic Aortic Disease
    Alexander J. Fletcher, Maaz B. J. Syed, Timothy J. Aitman, David Ernest Newby, Niki L. Walker · 2020 · Circulation
15. Periodontitis and Hypertension: Is the Association Causal?
    Rita Del Pinto, Davide Pietropaoli, Eva Muñoz Aguilera, Francesco D’Aiuto, Marta Cześnikiewicz‐Guzik, Annalisa Monaco, Tomasz Jan Guzik, Claudio Ferri · 2020 · High Blood Pressure & Cardiovascular Prevention
16. Tissue sodium excess is not hypertonic and reflects extracellular volume expansion
    Rossitto, Giacomo, Mary, Sheon, Chen, Jun Yu, Boder, Philipp, Chew, Khai Syuen, Neves, Karla B., Alves, Rheure L., Montezano, Augusto C., Welsh, Paul, Petrie, Mark C. et al. · 2020 · Nature Communications
17. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
    Luis Carlos Saiz, Javier Gorricho, Javier Garjón, Ma Concepción Celaya, Lourdes Muruzábal, Ma del Mar Malón, Rodolfo Montoya, Antonio López · 2017 · Cochrane Database of Systematic Reviews
18. Exercise and sport science australia position stand update on exercise and hypertension
    James E. Sharman, Neil A. Smart, Jeff Scott Coombes, Michael Stowasser · 2019 · Journal of Human Hypertension
19. Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment
    Oliver Jonathan Ziff, Monica Samra, James Philip Howard, Daniel I. Bromage, Frank Thomas Ruschitzka, Dárrel P. Francis, Dipak Kotecha · 2020 · BMC Medicine
20. Cardiovascular Event Risks Associated With Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study
    Fujiwara, Takeshi, Hoshide, Satoshi, Kanegae, Hiroshi, Kario, Kazuomi · 2020 · Hypertension
21. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
    Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Amedeo Lonardo · 2021 · Diagnostics
22. Home Blood Pressure Monitoring: Current Status and New Developments
    Kazuomi Kario · 2021 · American Journal of Hypertension
23. Exercise effects on cardiovascular disease: from basic aspects to clinical evidence
    Fabián Sanchis‐Gomar, Carl J. Lavie, Jorge Marín-Puyalto, Carme Pérez-Quilis, Thijs M.H. Eijsvogels, James Henry O’Keefe, Marco Valentin Perez, Steven N. Blair · 2021 · Cardiovascular Research
24. Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations
    Nikolaos Magkas, Costas P. Tsioufis, Costas Thomopoulos, Polychronis Dilaveris, Georgios A. Georgiopoulos, Elias A. Sanidas, Vasilios Papademetriou, Dimitrios M. Tousoulis · 2019 · Journal of Clinical Hypertension
25. A Narrative Review of the Patient Journey Through the Lens of Non-communicable Diseases in Low- and Middle-Income Countries
    Ratna Devi, Komal Kanitkar, Narendhar Ramasamy, Kawaldip Sehmi, Kannan Subramaniam · 2020 · Advances in Therapy
26. Coffee and Arterial Hypertension
    Stanisław Surma, Suzanne Oparil · 2021 · Current Hypertension Reports
27. Awareness, treatment, and control of hypertension in adults aged 45 years and over and their spouses in India: A nationally representative cross-sectional study
    Sanjay Kumar Mohanty, Sarang Pedgaonkar, Ashish Kumar Upadhyay, Fabrice Kämpfen, Prashant Shekhar, Radhe Shyam Mishra, Jürgen Maurer, Owen O’Donnell · 2021 · PLoS Medicine
28. Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases
    Jonatan Barrera‐Chimal, Benjamin Bonnard, Frédéric Jaisser · 2022 · Annual Review of Physiology
29. Performance of ChatGPT as an AI-assisted decision support tool in medicine: a proof-of-concept study for interpreting symptoms and management of common cardiac conditions (AMSTELHEART-2)
    Ralf E. Harskamp, Lukas De Clercq · 2024 · Acta cardiologica. Supplementum
30. Performance of ChatGPT as an AI-assisted decision support tool in medicine: a proof-of-concept study for interpreting symptoms and management of common cardiac conditions (AMSTELHEART-2)
    Harskamp, Ralf E., De Clercq, Lukas · 2023
31. Concentration of Branched-Chain Amino Acids Is a Strong Risk Marker for Incident Hypertension
    Jose Luis Flores-Guerrero, Dion Groothof, Margery A. Connelly, James D. Otvos, Stephan J. L. Bakker, Robin P. F. Dullaart · 2019 · Hypertension
32. The role of nutraceuticals in prevention and treatment of hypertension: An updated review of the literature
    Samad Ghaffari, Neda Roshanravan · 2019 · Food Research International
33. A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management
    Clara García-Carro, Ander Vergara, Sheila Bermejo, Maria Antonieta Azancot, Joana Sellarés, María José Soler · 2021 · Frontiers in Medicine
34. Landscape of cardiometabolic risk factors in Chinese population: a narrative review
    Jian‐Jun Li, Huihui Liu, Sha Li · 2022 · Cardiovascular Diabetology
35. Blood Pressure Variability and Progression of Clinical Alzheimer Disease
    de Heus, Rianne A.A., Olde Rikkert, Marcel G.M., Tully, Phillip J., Lawlor, Brian A., Claassen, Jurgen A.H.R., for the NILVAD Study Group · 2019 · Hypertension
36. Orthostatic hypertension: From pathophysiology to clinical applications and therapeutic considerations
    Nikolaos Magkas, Costas P. Tsioufis, Costas Thomopoulos, Polychronis Dilaveris, Georgios A. Georgiopoulos, Michael N. Doumas, Dimitris P. Papadopoulos, Dimitrios M. Tousoulis · 2019 · Journal of Clinical Hypertension
37. Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients
    Marius Miglinas, Ugne Cesniene, Marta Monika Janusaite, Artūras Vinikovas · 2020 · Frontiers in Cardiovascular Medicine
38. A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)
    Nigel David Toussaint, Eugenia Pedagogos, Nicole M. Lioufas, Grahame J. Elder, Elaine M. Pascoe, Sunil V. Badve, Andrea Valks, Geoffrey A. Block, Neil C Boudville, James D. Cameron et al. · 2020 · Journal of the American Society of Nephrology
39. High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health
    Cal Robinson, Rahul Chanchlani · 2022 · Kidney International Reports
40. Expert Consensus on the Clinical Use of Pulse Wave Velocity in Asia
    Jeong Bae Park, James E. Sharman, Yan Li, Masanori Munakata, Kohji Shirai, Chen‐Huan Chen, Sae Young Jae, Hirofumi Tomiyama, Hisanori Kosuge, Rosa María Bruno et al. · 2022 · Pulse
41. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study
    Zenglei Zhang, Lin Yang Zhao, Yiting Lu, Xu Meng, Xianliang Zhou · 2023 · Cardiovascular Diabetology
42. Physical Exercise for Individuals with Hypertension: It Is Time to Emphasize its Benefits on the Brain and Cognition
    Maria Luíza de Medeiros Rêgo, Daniel A.R. Cabral, Eduardo Caldas Costa, Eduardo Bodnariuc Fontes · 2019 · Clinical Medicine Insights Cardiology
43. Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
    Stefania Gorini, Seung Kyum Kim, Marco Infante, Caterina Mammi, Sandro La Vignera, Andrea Fabbri, Iris Zamir Jaffe, Massimiliano Caprio · 2019 · Frontiers in Endocrinology
44. Workload-indexed blood pressure response is superior to peak systolic blood pressure in predicting all-cause mortality
    Hedman, Kristofer, Cauwenberghs, Nicholas, Christle, Jeffrey W, Kuznetsova, Tatiana, Haddad, Francois, Myers, Jonathan · 2020 · European Journal of Preventive Cardiology
45. Could Anti‐Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID‐19 Infection? Data From Centers of Southern Italy
    Celestino Sardu, Paolo Maggi, Vincenzo Messina, Pasquale Iuliano, Antonio Sardu, Vincenzo Iovinella, Giuseppe Paolisso, Raffaele Marfella · 2020 · Journal of the American Heart Association
46. Arterial Hypertension in Women: State of the Art and Knowledge Gaps
    Niamh Chapman, Siew Mooi Ching, А. О. Конради, Anne Monique Nuyt, Taskeen Khan, Betty Twumasi-Ankrah, Eun J. Cho, Aletta Elisabeth Schutte, Rhian M. Touyz, U. Muscha Steckelings et al. · 2023 · Hypertension
47. Biomarkers to Guide Medical Therapy in Primary Aldosteronism
    Gregory L. Hundemer, Alexander A. C. Leung, Gregory A. Kline, Jenifer Michelle Brown, Adina F. Turcu, Anand Vaidya · 2023 · Endocrine Reviews
48. Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
    Rosa Lombardi, Lorena Airaghi, Giovanni Targher, Gaetano Serviddio, Gabriele Maffi, Alessandro Mantovani, Claudio Maffeis, Antonio Colecchia, Rosanna Villani, Luca Rinaldi et al. · 2019 · Liver International
49. The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations
    Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli · 2020 · European Journal of Internal Medicine
50. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update
    Claudio Borghi, Justyna Domienik‐Karłowicz, Andrzej Tykarski, Krystyna Widecka, Krzysztof Jerzy Filipiak, Milosz Jaroslaw Jaguszewski, Krzysztof Narkiewicz, Giuseppe Mancia · 2021 · Cardiology Journal
51. Understanding Treatment Adherence in Chronic Diseases: Challenges, Consequences, and Strategies for Improvement
    S. Patel, Ming‐Yi Huang, Sophia Miliara · 2025 · Journal of Clinical Medicine
52. Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study
    Ekaterina Sharashova, Tom Wilsgaard, Jocasta Ball, Bente Morseth, Eva Gerdts, Laila Arnesdatter Hopstock, Ellisiv Bøgeberg Mathiesen, Henrik Schirmer, Maja‐Lisa Løchen · 2019 · European Heart Journal
53. The beneficial health effects of flavonoids on the cardiovascular system: Focus on K+ channels
    Fabio Fusi, Alfonso Trezza, M Tramaglino, Giampietro Sgaragli, Simona Saponara, Ottavia Spiga · 2020 · Pharmacological Research
54. New Concept of Onco-Hypertension and Future Perspectives
    Satoshi Kidoguchi, Naoki Sugano, Goro Tokudome, Takashi Yokoo, Yuichiro Yano, Kiyohiko Hatake, Akira Nishiyama · 2020 · Hypertension
55. Arterial stiffness in health and disease: The role of cardio–ankle vascular index
    Toru Miyoshi, Hiroshi Ito · 2021 · Journal of Cardiology
56. Resistant Hypertension: Novel Insights
    Guillaume Lamirault, Mathieu Artifoni, Melanie Daniel, Nicolas Barber‐Chamoux, Nantes University Hospital Working Group on Hypertension · 2019 · Current Hypertension Reviews
57. Artificial Intelligence and Hypertension: Recent Advances and Future Outlook
    Thanat Chaikijurajai, Luke Joseph Laffin, W.H. Wilson Tang · 2020 · American Journal of Hypertension
58. Pre-existing and machine learning-based models for cardiovascular risk prediction
    Sang-Yeong Cho, Sun–Hwa Kim, Si‐Hyuck Kang, Kyong Joon Lee, Dongjun Choi, Seungjin Kang, Sang Jun Park, Tackeun Kim, Chang‐Hwan Yoon, Tae‐Jin Youn et al. · 2021 · Scientific Reports
59. Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: a comprehensive summary and update
    Florian von Knobelsdorff‐Brenkenhoff, Jeanette Schulz‐Menger · 2023 · Journal of Cardiovascular Magnetic Resonance
60. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China
    Chengping Hu, Jianwei Zhang, Jinxing Liu, Yan Liu, Ang Gao, Yong Zhu, Yingxin Zhao · 2020 · Cardiovascular Diabetology
61. Blood–brain barrier permeable β-blockers linked to lower risk of Alzheimer’s disease in hypertension
    Emily Eufaula Beaman, Anders Nissen Bonde, Sara Marie Ulv Larsen, Brice Ozenne, Terhi Johanna Lohela, Maiken Nedergaard, Gunnar Gislason, Gitte M. Knudsen, Sebastian C. Holst · 2022 · Brain
62. The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort
    Yuhao Yang, Shengxi Li, Qiao Ren, Yu Qiu, Mengjia Pan, Guanglei Liu, Rise Zheng, Zhenmei An, Shuangqing Li · 2024 · Cardiovascular Diabetology
63. Current status and therapeutic considerations of hypertension in the elderly
    Ju‐Hee Lee, Kwang‐Il Kim, Myeong‐Chan Cho · 2019 · The Korean Journal of Internal Medicine
64. Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults
    Gisella Pitter, Maryam Zare Jeddi, Giulia Barbieri, Massimo Gion, Aline S.C. Fabricio, Francesca Daprà, Francesca Russo, Tony Fletcher, Cristina Canova · 2020 · Environmental Health
65. Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
    Jan Thomas Kielstein, Roberto Pontremoli, Michel Burnier · 2020 · Current Hypertension Reports
66. Emergence of Home Blood Pressure-Guided Management of Hypertension Based on Global Evidence
    Kario, Kazuomi, Shimbo, Daichi, Hoshide, Satoshi, Wang, Ji-Guang, Asayama, Kei, Ohkubo, Takayoshi, Imai, Yutaka, McManus, Richard J., Kollias, Anastasios, Niiranen, Teemu J. et al. · 2019 · Hypertension
67. The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy
    Katharina Andrea Schuett, Nikolaus Marx, Michael Lehrke · 2023 · Circulation Research
68. Masked Hypertension: A Systematic Review
    Harsh V. Thakkar, Alun Pope, Mahesan Anpalahan · 2019 · Heart Lung and Circulation
69. Patient-Centric Cellular Networks Optimization Using Big Data Analytics
    Mohammed S. Hadi, Ahmed Q. Lawey, Taisir E. H. El-Gorashi, Jaafar M. H. Elmirghani · 2019 · IEEE Access
70. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline
    Ambarish Pandey, Kershaw V. Patel, Wanpen Vongpatanasin, Colby R. Ayers, Jarett D. Berry, Robert John Mentz, Michael Joseph Blaha, John William McEvoy, Paul Muntner, Muthiah Vaduganathan et al. · 2019 · Circulation
71. Artificial Intelligence in Hypertension
    Sandosh Padmanabhan, Tran Tran, Anna F. Dominiczak · 2021 · Circulation Research
72. Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People
    Chan Joo Lee, Ji-Yeon Lee, Kyungdo Han, Da Hye Kim, Hanna Cho, Kwang Joon Kim, Eun Seok Kang, Bong-Soo Cha, Yong‐ho Lee, Sungha Park · 2021 · Hypertension
73. International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL
    Farrukh Tauseef Awan, Daniel Addison, Feras Abdulaziz Alfraih, Sergio Baratta, Rodrigo Noronha Campos, María Silvana Cugliari, Yeow Tee Goh, В. А. Ионин, Stefanie Mundnich, Aaron Leonid Sverdlov et al. · 2022 · Blood Advances
74. Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study
    Roland Erich Schmieder, Sven Waßmann, Hans‐Georg Predel, Burkhard Weisser, Jörg Blettenberg, Anton Gillessen, Olaf Randerath, Antje Mevius, Thomas Wilke, Michael Böhm · 2023 · Hypertension
75. The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry
    Kongyong Cui, Rui Fu, Jingang Yang, Haiyan Xu, Dong Yin, Weihua Song, Hongjian Wang, Cheng‐Gang Zhu, Lei Feng, Zhifang Wang et al. · 2023 · Cardiovascular Diabetology
76. Association between Chinese visceral adiposity index and risk of stroke incidence in middle-aged and elderly Chinese population: evidence from a large national cohort study
    Zenglei Zhang, Lin Zhao, Yi-Ting Lu, Xu Meng, Xian-Liang Zhou · 2023 · Journal of Translational Medicine
77. Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association
    Stephen Paul Juraschek, Melissa M. Cortez, John M. Flack, Lama Ghazi, Rose Anne Kenny, Mahboob Rahman, Telisa A. Spikes, Cyndya A. Shibao, Italo Biaggioni · 2024 · Hypertension
78. Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins
    Keith C. Ferdinand, Fabrice Balavoine, B. Besse, Henry Richard Black, Stephanie Desbrandes, Howard C. Dittrich, Shawna D. Nesbitt, On behalf of the NEW HOPE Investigators · 2019 · Circulation
79. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation
    Michael Böhm, Norbert Frey, Evangelos Giannitsis, Karen S Sliwa, Andreas Michael Zeiher · 2020 · Clinical Research in Cardiology
80. Approach and Management of Hypertension After Kidney Transplantation
    Ekamol Tantisattamo, Miklos Zsolt Molnar, Bing Ho, Uttam G. Reddy, Donald C. Dafoe, Hirohito Ichii, Antoney Ferrey, Ramy Magdy Hanna, Kamyar Kalantar‐Zadeh, Alpesh Amin · 2020 · Frontiers in Medicine
81. The Story of the Silent Killer
    Jonathan P. Kalehoff, Suzanne Oparil · 2020 · Current Hypertension Reports
82. Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences
    Marco D’Abbondanza, Stefano Ministrini, Giacomo Pucci, Elisa Nulli Migliola, Eva Edvige Martorelli, V Baracco Gandolfo, Donatella Siepi, Graziana Lupattelli, Gaetano Vaudo · 2020 · Nutrients
83. Dietary Intervention to Improve Blood Pressure Control: Beyond Salt Restriction
    Arrigo F.G. Cicero, Maddalena Veronesi, Federica Fogacci · 2021 · High Blood Pressure & Cardiovascular Prevention
84. Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
    David E. Kandzari, Felix Mahfoud, Michael A. Weber, Raymond Townsend, Gianfranco Parati, Naomi D.L. Fisher, Melvin David Lobo, Michael Bloch, Michael Böhm, Andrew S.P. Sharp et al. · 2022 · Circulation
85. Normal reference values of multilayer longitudinal strain according to age decades in a healthy population: A single-centre experience
    Gianmarco Alcidi, Roberta Esposito, Vincenzo Evola, Ciro Santoro, Maria Lembo, Regina Sorrentino, Francesco Lo Iudice, Francesco Borgia, Giuseppina Novo, Bruno Trimarco et al. · 2017 · European Heart Journal - Cardiovascular Imaging
86. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
    Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José Manuel Boavida, Davide Capodanno et al. · 2022 · Revista Española de Cardiología
87. Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis
    Davor Vukadinović, Lucas Lauder, David E. Kandzari, Deepak L. Bhatt, Ajay Jayant Kirtane, Elazer Reuven Edelman, Roland Erich Schmieder, Michel Azizi, Michael Böhm, Felix Mahfoud · 2024 · Circulation
88. Prevalence, awareness, treatment, and control of hypertension in older people: results from the population-based KORA-age 1 study
    Samuel Muli, Christa Meisinger, Margit Heier, Barbara Thorand, Annette Peters, Ute Amann · 2020 · BMC Public Health
89. Aging and Renal Disease: Old Questions for New Challenges
    Yu‐Hsiang Chou, Yung‐Ming Chen · 2021 · Aging and Disease
90. Vascular Dysfunction of COVID-19 Is Partially Reverted in the Long-Term
    Luca Zanoli, Agostino Gaudio, Dimitri P. Mikhailidis, Niki Katsiki, Niccolò Castellino, Lorenzo Lo Cicero, Giulio Geraci, Concetto Sessa, Letizia Fiorito, Francesca Marino et al. · 2022 · Circulation Research
91. 2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action
    Norm R.C. Campbell, Paul Kieran Whelton, Marcelo Orías, Richard David Wainford, Francesco Paolo Cappuccio, Nicole Ide, Bruce Charles Neal, Jennifer Cohn, Laura K. Cobb, Jacqui L Webster et al. · 2022 · Journal of Human Hypertension
92. Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study
    Luqing Jiang, Tengxiao Zhu, Wenjing Song, Ying Zhai, Yu Rong Tang, Fugui Ruan, Zichen Xu, Lei Li, Xia Fu, Daoqin Liu et al. · 2025 · Cardiovascular Diabetology
93. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk
    Michael Böhm, Helmut Schumacher, Koon Kang Teo, Eva Lonn, Felix Mahfoud, Johannes F.E. Mann, Giuseppe Mancia, Josep Redón, Roland Erich Schmieder, Nikolaus Marx et al. · 2019 · European Heart Journal
94. 2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network
    Kario, Kazuomi, Park, Sungha, Chia, Yook‐Chin, Sukonthasarn, Apichard, Turana, Yuda, Shin, Jinho, Chen, Chen‐Huan, Buranakitjaroen, Peera, Divinagracia, Romeo, Nailes, Jennifer et al. · 2020 · The Journal of Clinical Hypertension
95. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals.
    Marios K. Georgakis, Rainer Malik, Harry Björkbacka, Tiberiu A. Pana, Serkalem Demissie, Colby R. Ayers, Mohamed A. Elhadad, Myriam Fornage, Alexa Beiser, Emelia J. Benjamin et al. · 2019 · PubMed
96. The Vasoactive Mas Receptor in Essential Hypertension
    Amalie Ling Povlsen, Daniela G. Grimm, Markus Wehland, Manfred Infanger, Marcus Krüger · 2020 · Journal of Clinical Medicine
97. Antihypertensive effect of quinoa protein under simulated gastrointestinal digestion and peptide characterization
    Huimin Guo, Yuqiong Hao, Aurore Richel, Nadia Everaert, Yinhuan Chen, Mengjie Liu, Xiushi Yang, Guixing Ren · 2020 · Journal of the Science of Food and Agriculture
98. Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study
    Pauline Boucheron, Grégory Lailler, E. Moutengou, Nolwenn Regnault, A. Gabet, Catherine Deneux‐Tharaux, Sandrine Kretz, Clémence Grave, Claire Mounier‐Véhier, Vassilis Tsatsaris et al. · 2021 · European Heart Journal
99. Management of hypertensive crisis: British and Irish Hypertension Society Position document
    Spoorthy Kulkarni, Mark Glover, Vikas Kapil, S. M. L. Abrams, Sarah Partridge, Terry McCormack, Peter S. Sever, Christian Delles, Ian B. Wilkinson · 2022 · Journal of Human Hypertension
100. Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve
     Valeria Visco, Carmine Izzo, Costantino Mancusi, Antonella Rispoli, Michele Tedeschi, Nicola Virtuoso, Angelo Giano, Renato Gioia, Americo Melfi, Bianca Serio et al. · 2023 · Journal of Cardiovascular Development and Disease